Advertisement

Cutaneous Lymphomas

  • Deniz Seçkin
  • Günther F.L. Hofbauer
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

Post-transplant lymphoproliferative disorders (PTLDs) are a clinically and morphologically heterogeneous group of lymphoid proliferations, affecting up to 5% of immunosuppressed patients following solid organ or bone marrow transplantation [1]. In transplant recipients, PTLDs are the second most common form of neoplasias after skin cancers [2], having a variable incidence that is 25- to 50 fold greater than that of the general population [3].

Keywords

Mycosis Fungoides Cutaneous Lymphoma Cutan Pathol Lymphomatoid Papulosis Extracorporeal Photopheresis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–91.PubMedCrossRefGoogle Scholar
  2. 2.
    Lutzner MA. Skin cancer in immunosuppressed organ transplant recipients. J Am Acad Dermatol 1984; 11:891–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Penn I. Cancer in immunosuppressed patients. Transplant Proc 1984; 16:492–4.PubMedGoogle Scholar
  4. 4.
    Beynet DP, Wee SA, Horwitz SS, et al. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. Arch Dermatol 2004; 140:1140–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Samolitis NJ, Bharadwaj JS, Weis JR, et al. Post-transplant lymphoproliferative disorder limited to the skin. J Cutan Pathol 2004; 31:453–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Jaffe ES, Harris NL, Stein H, et al. WHO Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.Google Scholar
  7. 7.
    Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323:1767–9.PubMedGoogle Scholar
  8. 8.
    Costes-Martineau V, Delfour C, Obled S, et al. Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review. J Clin Pathol 2002; 55:868–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978; 83:492–502.PubMedGoogle Scholar
  10. 10.
    Gonthier DM, Hartman G, Holley JL. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis 1992; 19:600–3.PubMedGoogle Scholar
  11. 11.
    McGregor JM, Yu CC, Lu QL, et al. Posttransplant cutaneous lymphoma. J Am Acad Dermatol 1993; 29:549–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Pacheco TR, Hinther L, Fitzpatrick J. Extramedullary plasmacytoma in cardiac transplant recipients. J Am Acad Dermatol 2003; 49:S255–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Verma S, Frambach GE, Seilstad KH, et al. Epstein–Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin. J Cutan Pathol 2005; 32:474–83.PubMedCrossRefGoogle Scholar
  14. 14.
    Chai C, White WL, Shea CR, et al. Epstein–Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol 1999; 26:242–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Blokx WA, Andriessen MP, van Hamersvelt HW, et al. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. Am J Dermatopathol 2002; 24:414–22.PubMedCrossRefGoogle Scholar
  16. 16.
    Bruce AJ, Subtil A, Rogers RS III, et al. Monomorphic Epstein–Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:e24–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Steinberg MJ, Herrera AF, Barakat RG. Posttransplant lymphoproliferative disorder resembling a chronic orocutaneous infection in an immunosuppressed patient. J Oral Maxillofac Surg 2004; 62:1033–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Schumann KW, Oriba HA, Bergfeld WF, et al. Cutaneous presentation of posttransplant lymphoproliferative disorder. J Am Acad Dermatol 2000; 42:923–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Oda D, Persson GR, Haigh WG, et al. Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation. Transplantation 1996; 61:435–40.Google Scholar
  20. 20.
    Nicol I, Boye T, Carsuzaa F, et al. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol 2003; 149:889–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Tessari G, Fabbian F, Colato C, et al. Primary cutaneous plasmacytoma after rejection of a transplanted kidney: case report and review of the literature. Int J Hematol 2004; 80:361–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Tas S, Simonart T, Dargent J, et al. Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation. Ann Dermatol Venereol 2000; 127:488–91.PubMedGoogle Scholar
  23. 23.
    Unholzer A, Starz H, Hirschsteiner O, et al. Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient. J Dtsch Dermatol Ges 2005; 3:46–51.PubMedGoogle Scholar
  24. 24.
    Lok C, Viseux V, Denoeux JP, et al. Post-transplant cutaneous T-cell lymphomas. Crit Rev Oncol Hematol 2005; 56:137–45.PubMedCrossRefGoogle Scholar
  25. 25.
    Seckin D, Demirhan B, Oguz Gulec T, et al. Posttransplantation primary cutaneous CD30 (Ki-1)-positive large-cell lymphoma. J Am Acad Dermatol 2001; 45:S197–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Ravat FE, Spittle MF, Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol 2006; 54:668–75.PubMedCrossRefGoogle Scholar
  27. 27.
    Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005; 32:647–74.PubMedCrossRefGoogle Scholar
  28. 28.
    Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768–85.PubMedCrossRefGoogle Scholar
  29. 29.
    Lucioni M, Ippoliti G, Campana C, et al. EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant 2004; 4:1915–20.PubMedCrossRefGoogle Scholar
  30. 30.
    Hoshida Y, Aozasa K. Malignancies in organ transplant recipients. Pathol Int 2004; 54:649–58.PubMedCrossRefGoogle Scholar
  31. 31.
    LaCasce AS. Post-transplant lymphoproliferative disorders. Oncologist 2006; 11:674–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein–Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997; 176:1462–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Verma S, Nuovo GJ, Porcu P, et al. Epstein–Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 2005; 32:35–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000; 96:3279–81.PubMedGoogle Scholar
  35. 35.
    Kremers WK, Devarbhavi HC, Wiesner RH, et al. Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. Am J Transplant 2006; 6:1017–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005; 56:155–67.PubMedCrossRefGoogle Scholar
  37. 37.
    Cerroni L, Zochling N, Putz B, et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24:457–61.PubMedCrossRefGoogle Scholar
  38. 38.
    Kaye FJ, Bunn PA Jr, Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321:1784–90.PubMedGoogle Scholar
  39. 39.
    Vonderheid EC, Tan ET, Kantor AF, et al. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 1989; 20:416–28.PubMedCrossRefGoogle Scholar
  40. 40.
    Zackheim HS, Epstein EH Jr, Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 1990; 22:802–10.PubMedCrossRefGoogle Scholar
  41. 41.
    Child FJ, Mitchell TJ, Whittaker SJ, et al. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides. Clin Exp Dermatol 2004; 29:231–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Stadler R, Otte HG, Luger T, et al. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998; 92:3578–81.PubMedGoogle Scholar
  43. 43.
    Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46:95–106.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Deniz Seçkin
    • 1
  • Günther F.L. Hofbauer
    • 2
  1. 1.Department of DermatologyFaculty of Medicine, Başkent UniversityAnkaraTurkey
  2. 2.Department of DermatologyUniversity Hospital,Zurich8091 ZurichSwitzerland

Personalised recommendations